MYH9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.700400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.059000E-03
Normal-vs-Stage2
8.615600E-02
Normal-vs-Stage3
1.648570E-01
Normal-vs-Stage4
3.208400E-01
Stage1-vs-Stage2
4.767900E-02
Stage1-vs-Stage3
2.814800E-01
Stage1-vs-Stage4
7.635700E-03
Stage2-vs-Stage3
6.664000E-01
Stage2-vs-Stage4
3.691800E-01
Stage3-vs-Stage4
3.493800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.728400E-02
Normal-vs-AfricanAmerican
1.001760E-01
Normal-vs-Asian
1.645640E-01
Caucasian-vs-AfricanAmerican
7.411200E-01
Caucasian-vs-Asian
8.688000E-01
AfricanAmerican-vs-Asian
8.761000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.235700E-02
Normal-vs-Female
9.884200E-02
Male-vs-Female
2.852000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.208400E-02
Normal-vs-Age(41-60Yrs)
6.586400E-02
Normal-vs-Age(61-80Yrs)
7.295800E-02
Normal-vs-Age(81-100Yrs)
1.107990E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.721800E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.134200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.212200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.475800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.406400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.651400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.378200E-02
Normal-vs-Daily Drinker
1.021900E-02
Normal-vs-Weekly Drinker
2.448800E-01
Normal-vs-Occasional Drinker
8.770000E-02
Normal-vs-Social Drinker
1.377370E-01
Non Drinker-vs-Daily Drinker
2.858000E-01
Non Drinker-vs-Weekly Drinker
2.552600E-01
Non Drinker-vs-Occasional Drinker
8.014200E-01
Non Drinker-vs-Social Drinker
6.482600E-01
Daily Drinker-vs-Weekly Drinker
3.281700E-02
Daily Drinker-vs-Occasional Drinker
1.971810E-01
Daily Drinker-vs-Social Drinker
1.526760E-01
Weekly Drinker-vs-Occasional Drinker
3.759600E-01
Weekly Drinker-vs-Social Drinker
5.326000E-01
Occasional Drinker-vs-Social Drinker
8.290200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.892200E-01
Normal-vs-Grade 2
1.305370E-01
Normal-vs-Grade 3
2.264200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.334440E-02
Grade 1-vs-Grade 3
1.648130E-02
Grade 1-vs-Grade 4
6.892200E-01
Grade 2-vs-Grade 3
7.953000E-01
Grade 2-vs-Grade 4
1.305370E-01
Grade 3-vs-Grade 4
2.264200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.154010E-01
Normal-vs-NonDiabetic
5.247900E-02
Diabetic-vs-NonDiabetic
9.201400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.291700E-02
Normal-vs-NoPancreatitis
7.734500E-02
Pancreatitis-vs-NoPancreatitis
9.458400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.035800E-02
Normal-vs-N1
9.759700E-02
N0-vs-N1
5.598200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.500200E-02
Normal-vs-TP53-NonMutant
8.981700E-03
TP53-Mutant-vs-TP53-NonMutant
4.710000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
